NIH

Dear Research Advocate, The Nobel prize winners announced this week showcase the role of both private sector (William Campbell’s work at Merck) and federal funding (Paul Modrich’s and Aziz Sancar's NIH and NSF grants) in driving scientific progress, and more broadly, the profound return science delivers to our nation and the world. Read our statements on the winners . The next few weeks are crucial for science funding and policies. Congressional leadership is working with the President to arrive at a budget deal that lifts the sequester caps, allowing for increases in NIH and other research agencies. If a deal lifting the caps is not made before Speaker Boehner retires, the new speaker (...
Could a 21 st Century Cures bill that modernizes the research ecosystem cross the finish line in Congress in the near future? We’re moving in the right direction, according to most of the panelists featured in POLITICO Pro’s “How Fast to Cures?” discussion on October 7, 2015 at the Newseum in Washington D.C. “For the first time in decades, with the House bill of 21 st Century Cures and with the Senate companion piece that they are working on, we’re seeing a revving up of our full ecosystem of discovery, development and delivery of medical progress that incorporates the patient community in ways that we’ve never seen,” said Mary Woolley, president and CEO, Research!America. Advocates should...
Dear Research Advocate: Pope Francis’ visit to Washington has been a breath of fresh air, but now Congress must get to work and reach a funding agreement that avoids a government shutdown beginning October 1st. Didn’t we learn from the last shutdown, just two years ago? Young patients were turned away from clinical trials at NIH. Disease outbreaks were not monitored because CDC epidemiologists were furloughed. Drugs, devices and other medical products pending FDA approval were delayed. All of this -- and much, much more -- was then and is now, entirely avoidable. Advocates should not be complacent; a government shutdown screams “broken government,” and should not even be on the table...
Dear Research Advocate, It was a privilege to address the terrific crowd at last night’s kick off reception for the American Association for Cancer Research (AACR) Rally for Medical Research. Forceful champions including Senators Durbin (D-IL), Moran (R-KS), Murray (D-WA) and Klobuchar (D-MN) joined NIH Director Francis Collins to thank and encourage the more than 300 advocates who are blanketing both Houses of Congress today. Adding in social media attention, the Rally is likely to reach every member of Congress. During remarks at a Rally breakfast this morning, House “Labor-H” Appropriations Subcommittee Chairman Tom Cole (R-OK-04) revved up the crowd when he said that “the stars are...
Dear Research Advocate: Research!America is proud to serve as a lead sponsor of the American Association for Cancer Research (AACR) Rally for Medical Research, a two-day event in Washington, DC next month. The Rally will unite individuals from across the medical research advocacy community to push for making National Institutes of Health (NIH) funding a higher national priority. Events begin on Wednesday, September 16 with an afternoon advocacy training and an evening congressional reception. On Thursday, after a breakfast featuring remarks by House Labor-HHS-Education Appropriations Subcommittee Chairman Tom Cole (R-OK-04), nearly 200 advocates will participate in Hill meetings. Add your...
Dear Research Advocate, Throughout its 26-year history, Research!America has been fortunate to attract extraordinarily gifted and dedicated national leaders to its Board of Directors. One such leader, the Honorable Louis Stokes, passed away on Tuesday . A powerhouse lawyer, founding member of the Congressional Black Caucus, skilled appropriator, and able chair of the House Ethics Committee, Lou was also a stalwart advocate for medical research and promoted efforts to address health disparities; in so many ways, Lou created a better future for all of us. Our fight for medical progress is, and will continue to be, part of his legacy. Current board member Dr. Herb Pardes wrote a compelling...
Dear Research Advocate, Research!America is on the Hill and in the media continuing to make the case for timely action in Congress to boost medical progress. I appreciated the opportunity to discuss the 21st Century Cures Act and the Senate’s Innovation initiative in a recent issue of Roll Call . The bottom line is this: we need to keep this ball rolling. Congress has a notoriously short attention span - too many issues, not enough time - so advocates should not only be pushing for what they want to see in the Senate bill, they should be pushing to see a Senate bill ASAP. Unless you’ve managed to steer clear of all forms of media in recent days, you probably know that the first official...
This op-ed appeared online on Roll Call July 31, 2015. New technology such as CRISPR-Cas9, a genuine scientific breakthrough, is raising hope for patients with cancer, cystic fibrosis, sickle-cell anemia and other major health threats. The gene editing tool, used in precision medicine, allows changes to be introduced into the DNA of any living cell— potentially enabling repair of disease causing mutations, neutralization of disease carrying insects, and much more. This technology, developed with support from the National Institutes of Health (NIH) and National Science Foundation (NSF), is an example of the realization of the promise of innovative research funded by our federal science...
Strange bedfellows? Not when it comes to research advocacy. On Monday, former House Speaker Newt Gingrich joined Senator Elizabeth Warren (D-MA) and Representative Elijah Cummings (D-MD-07) to press for more R&D in the bioscience arena. Not every topic is one on which Senator Warren and Speaker Gingrich agree , but they found common ground in the benefits that could come from another NIH doubling. The drumbeat for medical research continues apace. The Bipartisan Policy Center (BPC) released what is sure to be an influential report this week, Advancing Medical Innovation for a Healthier America . Focused on the development phase of the discovery, development, delivery continuum, the...
Dear Research Advocate: Congress has postponed further action on patent reform. Concern over provisions in the legislation poured in from a broad coalition within the life sciences community, including universities, patient advocates, and the pharmaceutical and biotech industries. BIO’s Jim Greenwood and PhRMA’s John Castellani penned a compelling op-ed on the topic for The Hill . Now there is more work to be done as policymakers and advocates continue the conversation about reforming our nation’s patent system. Stay tuned. Momentum for a two-year extension of the R&D tax credit is building in the Senate. The Senate Finance Committee, spearheaded by Senator Orrin Hatch (R-UT), voted...

Pages

Sidebar Quote

Without research, there is no hope.
The Honorable Paul G. Rogers